Microfluidic Cell Screening for Enzyme Phenotype Evaluation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a facile and generalized strategy for engineering diverse enzymes, particularly those that do not provide a selectable phenotype, such as glycosyltransferases, which hinders the evolution of enzymes with improved activity and novel catalytic functions.
Innovation Solution
The method involves isolating and evaluating variant cells in individual microreactors using microdevices with optical signal substrates to assess enzyme phenotypes based on substrate specificity and kinetic efficiency, allowing for the screening and selection of enzymes with desired properties, including the directed evolution of glycosyltransferases for enhanced catalytic performance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If traditional selection strategies (chemical complementation, phage display, bacterial cell surface display) are used to evolve enzymes without selectable phenotypes, then some screening capability is achieved, but the process lacks facilitation and generalization for engineering diverse enzymes
Solution Approach 1:
The patent replaces traditional mechanical/biological screening methods (phage display, cell surface display) with a microfluidic-based optical detection system. Individual cells are trapped in microwells and screened using optical signals that detect enzyme activity directly in solution, eliminating the need for complex biological display systems and enabling high-throughput screening of diverse enzymes including transferases.
Solution Approach 2:
The patent changes the detection parameter from requiring cell surface display or chemical complementation to direct optical detection of secreted enzymes. By using optical signal substrates that produce detectable signals when processed by target enzymes, the system enables screening of any secreted enzyme regardless of its natural phenotype, providing a generalized approach for engineering diverse enzymes.
2Measurement precision
If libraries of genetic variants are screened to identify enzymes with desired properties, then improved catalytic properties can be found, but the screening process becomes time-consuming and low-throughput
Solution Approach 1:
The patent segments the enzyme library into individual cells, each trapped in separate microwells within a microfluidic device. This spatial segmentation allows parallel screening of thousands of individual variants simultaneously, dramatically increasing throughput while maintaining the ability to evaluate each variant's phenotype with high precision through optical detection.
Solution Approach 2:
The patent performs preliminary spatial separation and confinement of cells in micrawells before screening. This preliminary action organizes the library in a format optimized for high-throughput optical detection, allowing rapid sequential or parallel screening without the time-consuming steps of traditional methods, thus improving both throughput and measurement precision.
3Measurement precision
If multiple parameters (substrate specificity, kinetic efficiency) are evaluated for enzyme phenotypes, then comprehensive enzyme characterization is achieved, but the complexity of the screening system increases
Solution Approach 1:
The patent employs universal optical signal substrates and detection methods that can evaluate multiple enzyme parameters (substrate specificity, kinetic efficiency) using the same basic platform. Different substrates with optical tags can be used to assess various catalytic properties, allowing comprehensive enzyme characterization without requiring separate specialized systems for each measurement.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the identification and development of enzymes with improved catalytic rates, substrate affinity, and altered substrate selectivity, facilitating the rapid and large-scale production of complex carbohydrates for therapeutic applications, such as carbohydrate-based cancer vaccines and antibiotics.
Implementation Method 1
The secreted enzyme variants are contacted with at least one optical signal substrate. Generally, the optical signal is indicative of a desired biomolecule phenotype or activity
Data Source
Figure 1
Figure 2
Figure 3~4
AI summary
The invention provides a method for isolating particular members from a library of variant cells in individual microreactors, wherein the phenotype of the biomolecule secreted by the cell is evaluated on the basis of multiple parameters, including substrate specificity and kinetic efficiency.